Rosler Ariel
Department of Endocrinology and Metabolism, Hebrew University, Hadassah Medical Center, Jerusalem, Israel.
Pediatr Endocrinol Rev. 2006 Aug;3 Suppl 3:455-61.
Eighty-five males with 17 beta-HSD3 were identified among a highly inbred Arab population in Israel and 57 studied over a period of 25 years. The founders of this defect originated in the mountainous regions of present Lebanon and Syria, but most of the families now live in Jerusalem, Hebron, the Tel-Aviv area and, in particular, in Gaza, where the frequency of affected males is estimated at 1 in 100 to 150. Affected individuals are born with ambiguity of the external genitalia and reared as females until puberty. Thereafter marked virilization occurs, leading in many cases to the spontaneous adoption of a male gender identity and role. Adults develop a male habitus with abundant body hair and beard and the phallus and testes enlarge to adult proportions. Gender reassignment in infancy was only possible when enough erectile tissue was present at birth and developed into a normal size penis with testosterone. 17 beta-HSD3 deficiency can be reliably diagnosed by endocrine evaluation and mutation analysis. In adults the defect is characterized by markedly increased concentrations of androstenedione (A) with borderline low to normal testosterone (T) levels and a high A/T ratio. 5a-dihydrotestosterone (DHT) concentrations are moderately decreased, normal or high and dehydroepiandrosterone (DHEA) levels are high. The estrogen pathway is also impaired, even though both estrone (E-1) and estradiol-17 beta (E-2) levels are high. Children have low basal levels of all androgens, but the defect may be demonstrated after prolonged stimulation with human chorionic gonadotropin (HCG). LH and FSH levels are very high after puberty and normal in childhood. 17 beta-HSD3 isozyme is encoded by the chromosome 9q22 17 beta-HSD3 gene and expressed exclusively in testes. A point mutation in exon 3, codon 80 of the 17 beta-HSD3 gene, R80Q, caused by a single base substitution from CGG ( arginine) to CAG ( glutamine) was identified in both alleles of 24 individuals from 9 extended Arab families from Gaza, Jerusalem and Lod-Ramle. Twenty-one homozygote males (46,XY) were MPH with testicular 17 beta-HSD3 deficiency whereas the three homozygote females (46,XX) were asymptomatic, had normal internal and external genitalia, normal sexual development and revealed no biochemical evidence of 17 beta-HSD3 deficiency. The molecular pattern is compatible with an autosomal recessive mode of inheritance, sex dependent.
在以色列一个高度近亲繁殖的阿拉伯人群中,发现了85名患有17β-羟类固醇脱氢酶3(17 beta-HSD3)缺陷的男性,其中57人经过了25年的研究。这种缺陷的最初患者来自现今黎巴嫩和叙利亚的山区,但现在大多数家庭居住在耶路撒冷、希伯伦、特拉维夫地区,尤其是加沙地带,据估计该地区受影响男性的发病率为1/100至1/150。受影响的个体出生时外生殖器模糊不清,在青春期前一直作为女性抚养。此后会出现明显的男性化,在许多情况下会导致个体自发地形成男性性别认同和角色。成年后,个体发育出具有浓密体毛和胡须的男性体型,阴茎和睾丸发育到成人大小。只有在出生时存在足够的勃起组织并在睾酮作用下发育成正常大小阴茎的情况下,才有可能在婴儿期进行性别重新分配。通过内分泌评估和突变分析可以可靠地诊断17β-羟类固醇脱氢酶3缺陷。在成年人中,该缺陷的特征是雄烯二酮(A)浓度显著升高,睾酮(T)水平临界低至正常,A/T比值高。5α-二氢睾酮(DHT)浓度中度降低、正常或升高,脱氢表雄酮(DHEA)水平升高。即使雌酮(E-1)和雌二醇-17β(E-2)水平都很高,雌激素途径也受到损害。儿童所有雄激素的基础水平都很低,但在人绒毛膜促性腺激素(HCG)长时间刺激后可能会显示出该缺陷。青春期后促黄体生成素(LH)和促卵泡生成素(FSH)水平非常高,儿童期则正常。17β-羟类固醇脱氢酶3同工酶由9号染色体q22的17β-羟类固醇脱氢酶3基因编码,仅在睾丸中表达。在来自加沙、耶路撒冷和罗德-拉姆勒的9个阿拉伯大家庭的24名个体的两个等位基因中,均发现了17β-羟类固醇脱氢酶3基因外显子3第80密码子的一个点突变,即R80Q,该突变由单个碱基从CGG(精氨酸)替换为CAG(谷氨酰胺)引起。21名纯合子男性(46,XY)患有睾丸17β-羟类固醇脱氢酶3缺乏症,表现为男性假两性畸形(MPH),而3名纯合子女性(46,XX)无症状,内外生殖器正常,性发育正常,且没有17β-羟类固醇脱氢酶3缺乏的生化证据。这种分子模式与常染色体隐性遗传模式相符,且具有性别依赖性。